Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „substrate“
Suchtreffer
Begriffe & Kennungen
Akeega · 4.5 · Effects of niraparib or abiraterone acetate on other medicinal products CYP2D6 substrates Abiraterone is an in
Eintrag öffnenAkynzeo · 4.5 · Interaction with CYP3A4 substrates
Eintrag öffnenAkynzeo · 4.5 · Interaction with CYP3A4 substrates
Eintrag öffnenAkynzeo · 4.5 · Interaction with CYP3A4 substrates
Eintrag öffnenAkynzeo · 4.5 · Interaction with CYP3A4 substrates:
Eintrag öffnenAkynzeo · 4.5 · Netupitant/palonosetron capsules are unlikely to interact with medicinal products which are P-gp substrates. N
Eintrag öffnenAkynzeo · 4.5 · Netupitant/palonosetron sachets are unlikely to interact with medicinal products which are P-gp substrates. Ne
Eintrag öffnenAlecensa · 4.5 · Breast cancer resistance protein (BCRP) substrates In vitro, alectinib and M4 are inhibitors of the efflux tra
Eintrag öffnenAlecensa · 4.5 · CYP substrates In vitro, alectinib and M4 show weak time-dependent inhibition of CYP3A4, and alectinib exhibit
Eintrag öffnenAlecensa · 4.5 · Effect of transporters on alectinib disposition M4 is a substrate of P-glycoprotein (P-gp). As alectinib inhib
Eintrag öffnenAlecensa · 4.5 · P-gp substrates In vitro, alectinib and its major active metabolite M4 are inhibitors of the efflux transporte
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Ambrisentan is a substrate for Pgp-mediated efflux.
Eintrag öffnenAngiotensinogen
Eintrag öffnenAnoro Ellipta (previously Anoro) · 4.5 · Both umeclidinium and vilanterol are substrates of the P-glycoprotein transporter (P-gp). The effect of the mo
Eintrag öffnenAnoro Ellipta (previously Anoro) · 4.5 · Umeclidinium is a substrate of cytochrome P450 2D6 (CYP2D6). The steady-state pharmacokinetics of umeclidinium
Eintrag öffnenAnoro Ellipta (previously Anoro) · 4.5 · Vilanterol is a substrate of cytochrome P450 3A4 (CYP3A4). Concomitant administration of strong CYP3A4 inhibit
Eintrag öffnenApixaban Accord · 4.5 · Digoxin Coadministration of apixaban (20 mg once a day) and digoxin (0.25 mg once a day), a P-gp substrate, di
Eintrag öffnenApixaban Accord · 4.5 · Digoxin Coadministration of apixaban (20 mg once a day) and digoxin (0.25 mg once a day), a P-gp substrate, di
Eintrag öffnenAptivus · 4.5 · 8 In vitro studies show that tipranavir is a substrate and also an inhibitor of P-gp.
Eintrag öffnenAptivus · 4.5 · Colchicine is a substrate of CYP3A4 and P-gp (an intestinal efflux transporter). Antibiotics Clarithromycin 50
Eintrag öffnen